MedTrace Logo

Improvement of Quality of Life in Patients Using Low-dose Pills in the Different Phases of Menacme

NCT01174524 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 100

Last updated 2010-08-03

No results posted yet for this study

Summary

The purpose of this study is to determine whether low-dose contraceptive pills are effective in the improvement of quality of life in patients in the different phases of menacme.

Conditions

Interventions

DRUG

gestoden 60 mcg

gestoden 60 mcg, once a day, administered in 24/4 regimen.

DRUG

ethinylestradiol 15 mcg

ethinylestradiol 15 mcg, once a day, administered in 24/4 regimen

Sponsors & Collaborators

  • Medley S∕A Indústria Farmacêutica

    collaborator UNKNOWN

  • Hospital Geral de Fortaleza

    lead OTHER_GOV

Principal Investigators

  • joao MM Silva, PhD Student · Hospital Geral de Fortaleza

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
15 Years
Max Age
46 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2008-01-31
Primary Completion
2008-11-30
Completion
2008-11-30

Countries

  • Brazil

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01174524 on ClinicalTrials.gov